Company Filing History:
Years Active: 2010
Title: Sigried Kiesling: Innovator in Immunotherapy
Introduction
Sigried Kiesling is a notable inventor based in Munich, Germany. He has made significant contributions to the field of immunotherapy, particularly through his innovative work on modified vaccinia virus Ankara (MVA) mutants. His research focuses on the prevention and therapy of various diseases, including cancer and infectious diseases.
Latest Patents
Kiesling holds a patent for a modified vaccinia virus Ankara (MVA) mutant and its use in immunotherapy and vaccination. This invention is directed towards utilizing the MVA mutant to enhance treatment options for numerous diseases, showcasing his commitment to advancing medical science.
Career Highlights
Kiesling is associated with the GSF-Forschungszentrum für Umwelt und Gesundheit GmbH, where he has been involved in groundbreaking research. His work has positioned him as a key figure in the development of innovative therapeutic strategies.
Collaborations
Throughout his career, Kiesling has collaborated with esteemed colleagues, including Caroline Staib and Gerd Sutter. These partnerships have further enriched his research and contributed to the advancement of immunotherapy.
Conclusion
Sigried Kiesling's contributions to the field of immunotherapy through his patented inventions highlight his role as an influential inventor. His work continues to pave the way for new treatment options in the fight against serious diseases.